Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 53

1.

Truvada PrEP: why I voted "yes".

Feinberg J.

Ann Intern Med. 2012 Oct 2;157(7):521-2. No abstract available.

PMID:
22820485
2.

Why I voted "no" to Truvada PrEP.

Wood LV.

Ann Intern Med. 2012 Oct 2;157(7):519-20. No abstract available.

PMID:
22821402
3.

Transmission. Company halts Truvada PrEP for women study.

[No authors listed]

AIDS Policy Law. 2011 Jun;26(7):1. No abstract available.

PMID:
21735622
4.

Preexposure prophylaxis: An emerging clinical approach to preventing HIV in high-risk adults.

Blackwell CW.

Nurse Pract. 2014 Sep 18;39(9):50-3. doi: 10.1097/01.NPR.0000452976.92052.fa. Review.

PMID:
25140852
5.

Preexposure prophylaxis for the prevention of HIV transmission to women.

Aaron E, Cohan D.

AIDS. 2013 Jan 2;27(1):F1-5. doi: 10.1097/QAD.0b013e32835917b4.

PMID:
22914582
6.

Emtricitabine/tenofovir (Truvada) for HIV prophylaxis.

Coutinho B, Prasad R.

Am Fam Physician. 2013 Oct 15;88(8):535-40. Review. No abstract available.

7.

HIV providers' perceived barriers and facilitators to implementing pre-exposure prophylaxis in care settings: a qualitative study.

Krakower D, Ware N, Mitty JA, Maloney K, Mayer KH.

AIDS Behav. 2014 Sep;18(9):1712-21. doi: 10.1007/s10461-014-0839-3.

8.
9.

Moving HIV PrEP from research into practice.

Landovitz RJ, Coates TJ.

Lancet Infect Dis. 2014 Sep;14(9):781-3. doi: 10.1016/S1473-3099(14)70747-9. Epub 2014 Jul 22. No abstract available.

PMID:
25065858
10.

Cost-effectiveness of pre-exposure prophylaxis (PrEP) in preventing HIV-1 infections in rural Zambia: a modeling study.

Nichols BE, Boucher CA, van Dijk JH, Thuma PE, Nouwen JL, Baltussen R, van de Wijgert J, Sloot PM, van de Vijver DA.

PLoS One. 2013;8(3):e59549. doi: 10.1371/journal.pone.0059549. Epub 2013 Mar 18.

11.

HIV prevention trials require sophisticated community preparation. Controversial PrEP trials serve as cautionary tale.

[No authors listed]

AIDS Alert. 2009 Jun;24(6):67-9. No abstract available.

PMID:
19544607
12.

Exposure ethics: does HIV pre-exposure prophylaxis raise ethical problems for the health care provider and policy maker?

Venter F, Allais L, Richter M.

Bioethics. 2014 Jul;28(6):269-74. doi: 10.1111/bioe.12021. Epub 2013 Jun 24.

PMID:
23796241
13.

Tenofovir: quo vadis anno 2012 (where is it going in the year 2012)?

De Clercq E.

Med Res Rev. 2012 Jul;32(4):765-85. doi: 10.1002/med.21267. Epub 2012 May 11. Review.

PMID:
22581627
14.

Better adherence leads to higher success in PrEP study.

[No authors listed]

AIDS Policy Law. 2013 Nov;29(1):3. No abstract available.

PMID:
24409549
15.

The performative function of expectations in translating treatment to prevention: the case of HIV pre-exposure prophylaxis, or PrEP.

Rosengarten M, Michael M.

Soc Sci Med. 2009 Oct;69(7):1049-55. doi: 10.1016/j.socscimed.2009.07.039. Epub 2009 Aug 18.

PMID:
19695756
16.

Where to deploy pre-exposure prophylaxis (PrEP) in sub-Saharan Africa?

Verguet S, Stalcup M, Walsh JA.

Sex Transm Infect. 2013 Dec;89(8):628-34. doi: 10.1136/sextrans-2012-050891. Epub 2013 Aug 2. Review.

PMID:
23912819
17.

Preparing for PrEP.

Lacor P.

Eur J Contracept Reprod Health Care. 2012 Dec;17(6):482-6. doi: 10.3109/13625187.2012.723225. Epub 2012 Oct 31.

PMID:
23113873
18.

Antiretroviral therapy and pre-exposure prophylaxis: combined impact on HIV transmission and drug resistance in South Africa.

Abbas UL, Glaubius R, Mubayi A, Hood G, Mellors JW.

J Infect Dis. 2013 Jul 15;208(2):224-34. doi: 10.1093/infdis/jit150. Epub 2013 Apr 9.

19.

Helping our patients take HIV pre-exposure prophylaxis (PrEP): a systematic review of adherence interventions.

Marcus JL, Buisker T, Horvath T, Amico KR, Fuchs JD, Buchbinder SP, Grant RM, Liu AY.

HIV Med. 2014 Aug;15(7):385-95. doi: 10.1111/hiv.12132. Epub 2014 Feb 24. Review.

20.

Awareness of, usage of and willingness to use HIV pre-exposure prophylaxis among men in downtown Toronto, Canada.

Leonardi M, Lee E, Tan DH.

Int J STD AIDS. 2011 Dec;22(12):738-41. doi: 10.1258/ijsa.2011.011057.

PMID:
22174057

Supplemental Content

Support Center